Ratings by TD Cowen (Marc Frahm)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Sana Biotechnology | SANA | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2026 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2026 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Monte Rosa Therapeutics | GLUE | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2025 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2025 | Repare Therapeutics | RPTX | Downgrade | Hold (Buy) |
1.65 (2.65) |
60.61% | Details | |
| 11/7/2025 | Puma Biotechnology | PBYI | Maintain | (N/A) |
|
Details | ||
| 10/29/2025 | Incyte | INCY | Maintain | (N/A) |
|
Details | ||
| 9/15/2025 | Monte Rosa Therapeutics | GLUE | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2025 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Theravance Biopharma | TBPH | Maintain | Hold (N/A) |
|
Details | ||
| 8/5/2025 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2025 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2025 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2025 | Elevation Oncology | ELEV | Downgrade | Hold (Buy) |
0.32 (0.37) |
15.63% | Details | |
| 6/4/2025 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2025 | Blueprint Medicines | BPMC | Downgrade | Hold (Buy) |
101.35 (129.46) |
27.74% | Details | |
| 5/19/2025 | Inozyme Pharma Inc. | INZY | Downgrade | Hold (Buy) |
1.42 (4.00) |
181.69% | Details | |
| 5/16/2025 | Inozyme Pharma Inc. | INZY | Downgrade | Hold (Buy) |
1.42 (4.00) |
181.69% | Details | |
| 3/10/2025 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | Theravance Biopharma | TBPH | Maintain | Hold (N/A) |
|
Details | ||
| 2/11/2025 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Sana Biotechnology | SANA | Upgrade | Buy (Hold) |
1.65 (3.15) |
90.91% | Details | |
| 12/3/2024 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2024 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | Monte Rosa Therapeutics | GLUE | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Inozyme Pharma Inc. | INZY | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Scholar Rock | SRRK | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2024 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2024 | Black Diamond Therapeutics | BDTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Nuvalent | NUVL | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2024 | Xilio Therapeutics Inc | XLO | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Gritstone bio | GRTS | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | Elevation Oncology | ELEV | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | Theravance Biopharma | TBPH | Maintain | Hold (N/A) |
|
Details | ||
| 7/16/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2024 | Monte Rosa Therapeutics | GLUE | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2024 | Elevation Oncology | ELEV | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2024 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2024 | Theravance Biopharma | TBPH | Maintain | Hold (N/A) |
|
Details | ||
| 4/24/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2024 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2023 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Theravance Biopharma | TBPH | Maintain | Hold (N/A) |
|
Details | ||
| 8/14/2023 | Sana Biotechnology | SANA | New Coverage | Hold (N/A) |
5.46 (1.65) |
-69.78% | Details | |
| 6/15/2023 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
0.00 (15.74) |
0% | Details | |
| 5/3/2023 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | DICE Therapeutics | DICE | New Coverage | Buy (N/A) |
29.84 (47.55) |
59.35% | Details | |
| 2/28/2023 | Theravance Biopharma | TBPH | Maintain | Hold (N/A) |
|
Details | ||
| 2/8/2023 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2023 | Magenta Therapeutics | MGTA | Downgrade | Hold (Buy) |
0.50 (0.70) |
40% | Details | |
| 12/13/2022 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2022 | Imago Biosciences Inc | IMGO | Downgrade | Hold (Buy) |
17.40 (36.01) |
106.95% | Details | |
| 11/8/2022 | Theravance Biopharma | TBPH | Maintain | Hold (N/A) |
|
Details | ||
| 12/13/2021 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2021 | Xilio Therapeutics Inc | XLO | New Coverage | Buy (N/A) |
22.20 (0.53) |
-97.61% | Details | |
| 9/15/2021 | Theravance Biopharma | TBPH | Maintain | Hold (N/A) |
|
Details | ||
| 8/24/2021 | Theravance Biopharma | TBPH | Downgrade | Hold (Buy) |
14.17 (13.57) |
-4.23% | Details | |
| 8/23/2021 | Nuvalent | NUVL | New Coverage | Buy (N/A) |
27.02 (99.41) |
267.91% | Details | |
| 8/10/2021 | Imago Biosciences Inc | IMGO | New Coverage | Buy (N/A) |
22.99 (17.40) |
-24.31% | Details | |
| 7/20/2021 | Elevation Oncology | ELEV | New Coverage | Buy (N/A) |
12.10 (0.32) |
-97.36% | Details | |
| 7/19/2021 | Monte Rosa Therapeutics | GLUE | New Coverage | Buy (N/A) |
19.29 (17.80) |
-7.72% | Details | |
| 7/6/2021 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
25.40 (13.84) |
-45.51% | Details | |
| 6/21/2021 | Day One Biopharmaceuticals | DAWN | New Coverage | Buy (N/A) |
21.00 (11.33) |
-46.05% | Details | |
| 6/3/2021 | Constellation Pharmaceuticals | CNST | Downgrade | Hold (Buy) |
20.24 (33.99) |
67.93% | Details | |
| 3/22/2021 | Odonate Therapeutics | ODT | Downgrade | Hold (Buy) |
19.03 (1.12) |
-94.11% | Details | |
| 3/2/2021 | Angion Biomedica | ANGN | New Coverage | Buy (N/A) |
19.92 (1.00) |
-94.98% | Details | |
| 2/18/2021 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2020 | Cardiff Oncology | CRDF | New Coverage | Buy (N/A) |
21.92 (1.88) |
-91.42% | Details | |
| 11/3/2020 | Shattuck Labs | STTK | New Coverage | Buy (N/A) |
26.87 (5.99) |
-77.71% | Details | |
| 8/18/2020 | Inozyme Pharma Inc. | INZY | New Coverage | Buy (N/A) |
29.00 (1.42) |
-95.1% | Details | |
| 5/13/2020 | Theravance Biopharma | TBPH | New Coverage | Buy (N/A) |
28.49 (13.57) |
-52.37% | Details | |
| 2/24/2020 | Black Diamond Therapeutics | BDTX | New Coverage | Buy (N/A) |
37.92 (2.15) |
-94.33% | Details | |
| 2/7/2020 | Constellation Pharmaceuticals | CNST | New Coverage | Buy (N/A) |
33.72 (33.99) |
0.8% | Details | |
| 1/3/2020 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2019 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2019 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2019 | X4 Pharmaceuticals | XFOR | New Coverage | Buy (N/A) |
14.82 (3.76) |
-74.63% | Details | |
| 4/22/2019 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2019 | Loxo Oncology | LOXO | Downgrade | Hold (Hold) |
139.87 (234.80) |
67.87% | Details | |
| 1/8/2019 | Eli Lilly | LLY | Downgrade | Hold (Buy) |
114.66 (990.33) |
763.71% | Details | |
| 12/7/2018 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2018 | Gritstone Oncology | GRTS | New Coverage | Buy (N/A) |
15.01 (0.03) |
-99.8% | Details |
